CDMO
Products & Pipeline
Therapeutic Areas
Menu
About us
Facilities
News
Careers
CDMO
Products & Pipeline
Therapeutic Areas
About us
Facilities
News
Careers
menu
Close
News
view details
March 27, 2023
Evergreen Theragnostics Completes $15M Series B, Launches Discovery Unit, and Prepares Ga-68 DOTATOC Supply Chain
view details
December 12, 2022
Evergreen Theragnostics Submits New Drug Application for Gallium-68 DOTATOC Kit with US FDA
view details
August 18, 2022
Clarity and Evergreen expand Targeted Copper Theranostics manufacturing
view details
March 16, 2022
Clovis Oncology and Evergreen Theragnostics Initiate Development and Manufacturing Services Agreement for Actinium-225-Labeled FAP-2286
view details
December 1, 2021
MTTI partners with Evergreen to manufacture EvaThera platform of radiopharmaceuticals
view details
October 18, 2021
Evergreen Theragnostics Completes New Jersey Manufacturing Facility
view details
September 30, 2021
Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement for US clinical trials
view details
August 16, 2021
Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131
view details
July 14, 2021
Evergreen Theragnostics Expands Alpha Radiopharmaceutical Production Capabilities
1
...
